MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
PR Newswire

Christmas Shopping 2009: Will the British be Deterred by Swine Flu?

- 2 out of 3 Brits Plan Online Shopping to Reduce the Risk of Contracting the Virus

— LONDON, November 3

LONDON, November 3 /PRNewswire/ -- Twenga, the comprehensive shopping search engine, today reveals further results from its annual Christmas Spending Survey. The company asked over 3000 Europeans if their Christmas shopping would be affected by the Swine Flu virus H1N1. The results show that the British are more fearful of contracting the virus than their European counterparts with 2 out of 3 (65%) British shoppers saying they are planning more online shopping for Christmas 2009. This compares to the European average of 49% where the Spanish and Dutch were least bothered, both at 37%.

Contact - Jodie Weltonjodie@connectedpr.eu +44(0)7887-780-464

Related news

Related News

Genetic Study Shows Direct Link Between Vitamin D and Ms Susceptibility 'Gene'
Arrayit to Mass Produce Rapid H1N1 Swine Flu Test Chip
Swine Flu: Filtering Fact From Fiction About Face Masks
DialAFlight Announce Bookings Upsurge After Swine Scare
Unit Clothing Mask Up to Combat Swine Flu
Merck Serono Launches RebiSmart(TM), First Electronic Injection Device for Delivery of Multiple Sclerosis Treatment Rebif(R)
High-Tech 'Smart' Face Mask Helps Hong Kong Families Combat Swine Flu
NanoPass Makes its MicronJet Technology Available to Increase Global Supply of Pandemic Influenza Vaccines
Results of RebiSmart(TM) User Trial Presented at 25th ECTRIMS Congress Show Broad Patient Acceptance of the New Electronic Delivery Device for Relapsing Multiple Sclerosis Treatment Rebif(R)
Investment in Health Benefits is on the Up

Latest News

ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities
Merck Serono to Expand Research and Development Presence in China
Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation
International Operation Combats Online Supply of Counterfeit and Illegal Medicines
Marketing Authorisation Application for S-1 Validated by European Medicines Agency
Photos: P&G Voluntarily Recalls Specific Lots of Vicks Sinex Nasal Spray in the United States, Germany and the United Kingdom
Medicines Top Counterfeit Concern List in Europe - Consumers Call for Tougher Safety Measures
VerifyNow(R) System Highlighted in POPular Study Comparing Platelet Reactivity Tests
Visage Imaging Signs University of Chicago
Contact Centre Services to Take Off in Nigeria by 2015, Finds Frost & Sullivan

See also

Deals review
Press releases
Industry news
PR Newswire
Company directory
PL Intelligence

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Need competitive intelligence information
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us